Viewing Study NCT02252861


Ignite Creation Date: 2025-12-24 @ 12:04 PM
Ignite Modification Date: 2025-12-28 @ 6:50 AM
Study NCT ID: NCT02252861
Status: COMPLETED
Last Update Posted: 2021-02-09
First Post: 2014-09-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: French Database of Left Atrial Appendage Closure
Sponsor: Henri Mondor University Hospital
Organization:

Study Overview

Official Title: French Database of Left Atrial Appendage Closure
Status: COMPLETED
Status Verified Date: 2021-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: FLAAC
Brief Summary: Patients with atrial fibrillation are exposed to a high risk of thrombus in the left atrium that can induce cerebral vascular events or systemic embolisms. This justifies the prescription of anticoagulant therapies in patients with high risk of thromboembolic event. Percutaneous left atrial appendage closure is a new interventional strategy for patients with high risk of cardiovascular events and a counter-indication for long term treatment with anticoagulant agents. However, only few data are available on effectiveness and prognosis of patients treated by this new interventional strategy.

This national database record per-procedure and follow-up data of patients treated by left atrial appendage closure.

This database is strictly observational.

Percutaneous left atrial appendage closure is performed only for the purpose of patient care. No specific intervention is performed specifically for the database. Neither left atrial appendage closure procedure nor patient follow up are modified by patient inclusion in the database.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: